Want to see AU:IMU full AI Analyst Report?
Imugene (IMU) Stock Statistics & Valuation Metrics
Total Valuation
Imugene has a market cap or net worth of AUD 18.14M. The enterprise value is AUD 43.81M.
- Market Cap
- AUD 18.14M
- Enterprise Value
- AUD 43.81M
Share Statistics
Imugene has 549,574,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 549,574,700
- Owned by Insiders
- 3.17%
- Owned by Institutions
- 0.67%
Financial Efficiency
Imugene’s return on equity (ROE) is -11.69 and return on invested capital (ROIC) is -480.51%.
- Return on Equity (ROE)
- -11.69
- Return on Assets (ROA)
- -4.57
- Return on Invested Capital (ROIC)
- -480.51%
- Return on Capital Employed (ROCE)
- -8.32
- Revenue Per Employee
- 0
- Profits Per Employee
- -7.52M
- Employee Count
- 14
- Asset Turnover
- 0.00
- Inventory Turnover
- 1.55
Valuation Ratios
The current PE Ratio of Imugene is -0.10. Imugene’s PEG ratio is 0.00.
- PE Ratio
- -0.10
- PS Ratio
- 0.00
- PB Ratio
- 1.24
- Price to FCF
- -0.39
- Price to Operating Cash Flow
- -0.25
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Imugene had revenue of 0 and earned -105.34M in profits. Earnings per share was -0.32.
- Revenue
- 0
- Gross Profit
- -6.84M
- Operating Income
- -74.95M
- Pretax Income
- -107.34M
- Net Income
- -105.34M
- EBITDA
- -68.11M
- Earnings Per Share (EPS)
- -0.32
Cash Flow
In the last 12 months, operating cash flow was -44.85M and capital expenditures -3, giving a free cash flow of -44.85M billion.
- Operating Cash Flow
- -44.85M
- Free Cash Flow
- -44.85M
- Free Cash Flow per Share
- -0.13
Dividends & Yields
Imugene pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -272.06%
- Earnings Yield
- -1005.90%
Stock Price Statistics
- Beta
- 2.39
- 52-Week Price Change
- -91.43%
- 50-Day Moving Average
- 0.05
- 200-Day Moving Average
- 0.12
- Relative Strength Index (RSI)
- 31.41
- Average Volume (3m)
- 2.72M
Important Dates
Imugene upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 02, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Imugene as a current ratio of 0.70, with Debt / Equity ratio of 69.91%
- Current Ratio
- 0.70
- Quick Ratio
- 0.39
- Debt to Market Cap
- 0.17
- Net Debt to EBITDA
- -0.05
- Interest Coverage Ratio
- -597.34
Taxes
In the past 12 months, Imugene has paid -2.00M in taxes.
- Income Tax
- -2.00M
- Effective Tax Rate
- 0.02
Enterprise Valuation
Imugene EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -0.45.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.28
- EV to Free Cash Flow
- -0.45
- EV to Operating Cash Flow
- -0.45
Balance Sheet
Imugene has AUD 2.63M in cash and marketable securities with AUD 6.30M in debt, giving a net cash position of -AUD 3.67M billion.
- Cash & Marketable Securities
- AUD 2.63M
- Total Debt
- AUD 6.30M
- Net Cash
- -AUD 3.67M
- Net Cash Per Share
- -AUD 0.01
- Tangible Book Value Per Share
- AUD 0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Imugene is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -2.15%
Scores
- Smart Score
- 4
- AI Score
- 42
